(Q38188226)

English

Exploiting epigenetic vulnerabilities for cancer therapeutics

scientific article published on 12 February 2014

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24529765

retrieved

30 August 2017

title

Exploiting epigenetic vulnerabilities for cancer therapeutics (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

30 August 2017

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24529765

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24529765%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 June 2020

Stefan Kubicek

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24529765

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24529765%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 June 2020

Sebastian Nijman

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24529765

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24529765%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 June 2020

author name string

Barbara Mair

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24529765

retrieved

30 August 2017

Stefan Kubicek

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24529765

retrieved

30 August 2017

Sebastian M B Nijman

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24529765

retrieved

30 August 2017

publication date

12 February 2014

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24529765

retrieved

30 August 2017

published in

Trends in Pharmacological Sciences

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24529765

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24529765%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 June 2020

volume

35

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24529765

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24529765%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 June 2020

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24529765

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24529765%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 June 2020

page(s)

136-145

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24529765

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24529765%20AND%20SRC:MED&resulttype=core&format=json

(Q38188226)

Exploiting epigenetic vulnerabilities for cancer therapeutics

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)